NPPB and Obesity: The exploratory subgroup analyses (eGFR, obesity, GDMT use in HFrEF, baseline NT-proBNP, and baseline mean PA pressure) did not show any clinically relevant interaction effects in the quality of life, clinical and PA pressure endpoints.